Dr. Prantesh Jain, MD

Dr. Jain practices at Roswell Park Cancer Institute in Los Angeles, California.

Dr. Jain's NPI, 1710295019, was assigned on September 21, 2010. Dr. Jain holds New York license 311125.

Dr. Jain's primary practice is Roswell Park Cancer Institute, at 344 S Hauser Blvd, Los Angeles, CA 90036 in Los Angeles County. The practice phone is (716) 845-2300.

Dr. Jain's primary practice is Roswell Park Cancer Institute in Los Angeles, California. Dr. Jain is also affiliated with Roswell Park Comprehensive Cancer Center. The medical group on file is Roswell Park Comprehensive Cancer Center.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Jain practices. Vendor and product names are available with a free account.

Medical oncology is Dr. Jain's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dmand AI has Dr. Jain's licenses on file in 2 states: New York and Illinois.

CMS data shows 124 Medicare services from Dr. Jain across 3 procedure codes in 2024, all of them office visits, for 67 Medicare patients. Medicare paid $12,759 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 67 Medicare patients who saw Dr. Jain in 2024. The largest group is 65 to 74, with 34 patients. 75% of them have cancer, and 75% have high cholesterol. 28% are also on Medicaid. Their average risk score is 3.12, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Jain's median patient age at 72, with 52% women.

In 2024, Dr. Jain wrote 188 Medicare Part D claims for 63 patients. 64% of them were for generic drugs. CMS names the drug for 78 of them, across 4 drugs with 11 or more claims each, at $722,494 in total drug cost. In 2023, CMS named 132 claims across 7 drugs.

Dr. Jain accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Jain as offering telehealth.

Dmand AI links 22 papers to Dr. Jain, published from 2018 to 2025. 2021 was the busiest year, with 4. The most frequent topics are Lung Neoplasms, Carcinoma, Non-Small-Cell Lung and Immunotherapy. Dr. Jain has published most often in Clin Lung Cancer. Dr. Jain's most frequent co-authors are Vamsidhar Velcheti, MD, Avirup Guha, MBBS and Kaustav Bera, MBBS.

CMS Open Payments shows 33 general payments to Dr. Jain from 17 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 70% of the total. Amgen Inc. paid the most, $3,496.